Is IVMED or MCD a better dividend investment in 2026?

IVMED currently yields 285714.29% with a 5% 5-year dividend growth rate. MCD yields 2.34% with 8.5% growth. The better choice depends on your goal: IVMED offers higher current income.

What is the dividend yield difference between IVMED and MCD?

IVMED has a forward dividend yield of 285714.29% ($2.00/share annually). MCD yields 2.34% ($7.26/share annually). The yield gap is 285711.95 percentage points.

Home › Compare › IVMED vs MCD

IVMED vs MCD: Dividend Comparison 2026

IVMED yields 285714.29% · MCD yields 2.34%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IVMED wins by $1.734986541242196e+31M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IVMED

● Live price

285714.29%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.734986541242196e+31M

Annual income

$17,337,928,197,276,910,000,000,000,000,000,000,000.00

Full IVMED calculator →

MCD

McDonald's Corporation

● Live price

2.34%

Share price

$310.79

Annual div

$7.26

5Y div CAGR

42.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$77.7K

Annual income

$25,833.37

Full MCD calculator →

Portfolio growth — IVMED vs MCD

📍 IVMED pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IVMED	MCD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IVMED + MCD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IVMED pays

MCD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVMED

Annual income on $10K today (after 15% tax)

$24,285,714.29/yr

After 10yr DRIP, annual income (after tax)

$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr

MCD

Annual income on $10K today (after 15% tax)

$198.56/yr

After 10yr DRIP, annual income (after tax)

$21,958.36/yr

At 15% tax rate, IVMED beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVMED + MCD for your $10,000?

IVMED: 50%MCD: 50%

100% MCD50/50100% IVMED

Portfolio after 10yr

$8.67493270621098e+30M

Annual income

$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr

Blended yield

99.93%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

IVMED

No analyst data

Altman Z

-205.3

Piotroski

2/9

MCD

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$351.76

+13.2% upside vs current

Range: $320.00 — $385.00

Altman Z

4.9

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVMED buys

MCD buys

No recent congressional trades found for IVMED or MCD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIVMEDMCD

Forward yield	285714.29% ✓	2.34%
Annual dividend / share	$2.00	$7.26 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	42.3% ✓
Portfolio after 10y	$1.734986541242196e+31M	$77.7K ✓
Annual income after 10y	$17,337,928,197,276,910,000,000,000,000,000,000,000.00 ✓	$25,833.37
Total dividends collected	$1.734908400352195e+31M	$57.7K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary

Year-by-year: IVMED vs MCD ($10,000, DRIP)

Year	IVMED Portfolio	IVMED Income/yr	MCD Portfolio	MCD Income/yr	Gap
1← crossover	$28,582,129	$28,571,428.57	$10,812	$332.41	+$28.57M → IVMED
2	$76,351,353,429	$76,320,770,551.21	$11,819	$488.02	+$76351.34M → IVMED
3	$190,619,493,207,524	$190,537,797,259,355.30	$13,111	$724.37	+$190619493.19M → IVMED
4	$444,781,927,427,195,200	$444,577,964,569,463,100.00	$14,832	$1,091.05	+$444781927427.18M → IVMED
5	$969,967,353,346,567,200,000	$969,491,436,684,220,000,000.00	$17,219	$1,675.85	+$969967353346567.13M → IVMED
6	$1,976,961,629,315,093,000,000,000	$1,975,923,764,247,012,300,000,000.00	$20,688	$2,641.85	+$1976961629315092992.00M → IVMED
7	$3,765,923,944,594,039,000,000,000,000	$3,763,808,595,650,671,000,000,000,000.00	$25,990	$4,309.70	+$3.765923944594039e+21M → IVMED
8	$6,704,681,437,057,684,000,000,000,000,000	$6,700,651,898,436,968,000,000,000,000,000.00	$34,590	$7,351.77	+$6.704681437057683e+24M → IVMED
9	$11,156,275,836,497,016,000,000,000,000,000,000	$11,149,101,827,359,364,000,000,000,000,000,000.00	$49,535	$13,285.25	+$1.1156275836497015e+28M → IVMED
10	$17,349,865,412,421,960,000,000,000,000,000,000,000	$17,337,928,197,276,910,000,000,000,000,000,000,000.00	$77,746	$25,833.37	+$1.734986541242196e+31M → IVMED

IVMED vs MCD: Complete Analysis 2026

IVMED — Stock

Whitebeard Inc., a development stage company, engages in the research and development of medical devices with `near-patient' testing applications. Its primary product includes prothrombin monitor, which is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke. The company's other products under development include predictor of labor onset, a consumer device for maternity planning; biomarker monitor for the measurement of a number of biomarkers, including heart attack, HIV, cholesterol, and cancer; blood glucose monitor, a noninvasive glucose concentration continuous bulk measuring device measurement; digital scanning machine, a noninvasive alternative to 2D X-ray scanning; osteoporosis detection and monitoring device, an instant display of bonemineral density for osteoporosis patients; and hand held digital strip reader for immunoassay applications. It was formerly known as In Vivo Medical Diagnostics, Inc. and changed its name to In Veritas Medical Diagnostics, Inc. in 2005. The company is based in Inverness, the United Kingdom.

Full IVMED Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →

📬

Get this IVMED vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVMED vs SCHD IVMED vs JEPI IVMED vs O IVMED vs KO IVMED vs MAIN IVMED vs YUM IVMED vs QSR IVMED vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.